Mariko Muta
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Macrophage Migration Inhibitory Factor
- Oncology top 5%
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
Papers in
-
- NF-κB Signaling Pathways 3
- Breast Cancer Treatment Studies 2
- Oncology 11
- Chemokine receptors and signaling 3
- Vascular Tumors and Angiosarcomas 2
- Co-authors
- Masakazu Toi (20 shared papers)Hiroko Bando (8 shared papers)Morio Koike (3 shared papers)Takayuki Ueno (4 shared papers)Katsumasa Kuroi (3 shared papers)Hisashi Saji (1 shared paper)Kouji Matsushima (1 shared paper)Hidekuni Inadera (1 shared paper)
- Journals
- Oncology Reports (5 papers)Clinical Cancer Research (3 papers)International Journal of Cancer (2 papers)Drug Metabolism and Pharmacokinetics (1 paper)Oncology (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Mariko Muta
24 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Immunology 554
- Oncology 670
- Cancer Research 328
- Immunology and Allergy 57
- Molecular Biology 554
Countries citing papers authored by Mariko Muta
This map shows the geographic impact of Mariko Muta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Muta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Muta more than expected).
Fields of papers citing papers by Mariko Muta
This network shows the impact of papers produced by Mariko Muta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Muta. The network helps show where Mariko Muta may publish in the future.
Co-authors
The 25 scholars most cited alongside Mariko Muta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. | 2000 | 648 |
| 2 | 2001 | 115 | |
| 3 | 2002 | 97 | |
| 4 | 2007 | 95 | |
| 5 | Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. | 2005 | 93 |
| 6 | 2005 | 80 | |
| 7 | 2004 | 42 | |
| 8 | 1998 | 36 | |
| 9 | 2007 | 31 | |
| 10 | 1999 | 30 | |
| 11 | 2012 | 24 | |
| 12 | 2010 | 21 | |
| 13 | 2009 | 18 | |
| 14 | 2001 | 18 | |
| 15 | 2003 | 16 | |
| 16 | 2005 | 15 | |
| 17 | 2003 | 14 | |
| 18 | 2007 | 14 | |
| 19 | 2006 | 11 | |
| 20 | 2003 | 9 |
About Mariko Muta
Mariko Muta is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Toxicology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), NF-κB Signaling Pathways (3 papers), Chemokine receptors and signaling (3 papers), TGF-β signaling in diseases (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Estrogen and related hormone effects (2 papers), Breast Cancer Treatment Studies (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Immunology (554 citations), Oncology (670 citations), Cancer Research (328 citations), Immunology and Allergy (57 citations) and Molecular Biology (554 citations). Mariko Muta has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Masakazu Toi, Hiroko Bando, Morio Koike, Takayuki Ueno, Katsumasa Kuroi, Hisashi Saji, Kouji Matsushima, Hidekuni Inadera, Gaku Matsumoto and Taeko Ogawa. Their work appears in journals such as Oncology Reports, Clinical Cancer Research, International Journal of Cancer, Drug Metabolism and Pharmacokinetics and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.